The Top Plant-based Food Stocks to Watch in New Year 2020

Financialnewsmedia.com News Commentary

PALM BEACH, Florida, Feb. 19, 2020 /PRNewswire/ -- At the moment, 55% of Americans have added plant-based foods to their diets, according to Food Business News. Better, according to an NBC News report, market research firm "NPD found that 16 percent of Americans say they 'regularly' use plant-based alternatives to meat and dairy products, such as almond milk and meat substitutes. More unexpected, though, is that 89 percent of the people eating all of these tell NPD that they're not vegetarian or vegan — they just like variety in their diets." Fast food giants are jumping on the trend, as well, including McDonald's, Burger King, White Castle, Dunkin, and even Starbucks. It's all creating sizable opportunity for companies such as Else Nutrition Holdings Inc. (TSX-V: BABY)(OTCQB: BABYF), Burcon NutraScience Corp. (TSX:BSU)(OTCQB:BUROF), Beyond Meat Inc. (NASDAQ:BYND), Kellogg Company (NYSE:K), and Tyson Foods Inc. (NYSE:TSN).

Else Nutrition Holdings Inc. (TSX-V: BABY)(OTCQB: BABYF) BREAKING NEWS: Else Nutrition Holdings Inc., a developer of novel plant based infant nutrition is pleased to announce that it has entered into a investment agreement with NewH² Limited, a subsidiary of Health and Happiness (H&H) International Holdings Limited, a Hong Kong Stock Exchange Company (HK:1112), pursuant to which NewH² has agreed to an investment of C$5.75 million in the Company, as part of an aggregate private placement offering of up to C$8.0 million. Pursuant to the private placement the Company will issue up to 12,383,900 (the "Units") at a price of C$0.646 per Unit. Each Unit will consist of one common share and 0.25 share purchase warrants, with each whole warrant (a "Warrant") entitling the holder to acquire one additional common share of the Company at an exercise price of C$0.969 per share for a period of thirty months from the closing date. NewH² has agreed to purchase 8,900,928 of the Units being offered which will represent approximately 11.15% of the Company's issued and outstanding common shares assuming all Units are sold. On closing of the offering, NewH² and the Company will enter into an investor rights agreement pursuant to which NewH² will be granted certain rights to maintain its percentage holdings of common shares in the Company through participation in future financings, and the right to hold one board seat on the Company's board of directors. Closing of the offering is expected to occur on or about February 26, 2020, and is subject to obtaining stock exchange approval.